Skip to main content

Activation vs. Organization: Prognostic Implications of T and B Cell Features of the PDAC Microenvironment

  • Conference paper
  • First Online:
Mathematical and Computational Oncology (ISMCO 2020)

Abstract

Pancreatic ductal adenocarcinoma (PDAC) patients, who often present with stage III or IV disease, face a dismal prognosis as the 5-year survival rate remains below 10%. Recent studies have revealed that CD4\(^+\) T, CD8\(^+\) T, and/or B cells in specific spatial arrangements relative to intratumoral regions correlate with clinical outcome for patients, but the complex functional states of those immune cell types remain to be incorporated into prognostic biomarker studies. Here, we developed an interpretable machine learning model to analyze the functional relationship between leukocyte-leukocyte or leukocyte-tumor cell spatial proximity, correlated with clinical outcome of 46 therapy-naïve PDAC patients following surgical resection. Using a multiplex immunohistochemistry imaging data set focused on profiling leukocyte functional status, our model identified features that distinguished patients in the fourth quartile from those in the first quartile of survival. The top ranked important features identified by our model, all of which were positive prognostic stratifiers, included CD4 T helper cell frequency among CD45\(^+\) immune cells, frequency of Granzyme B-positivity among CD4 and CD8 T cells, as well as the frequency of PD-1 positivity among CD8 T cells. The spatial proximity of CD4 T- to B cells, and between CD8 T cells and epithelial cells, were also identified as important prognostic features. While spatial proximity features provided valuable prognostic information, the best model required both spatial and phenotypic information about tumor infiltrating leukocytes. Our analysis links the immune microenvironment of PDAC tumors to outcome of patients, thus identifying features associated with more progressive disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Binnewies, M., et al.: Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24(5), 541–550 (2018). https://doi.org/10.1038/s41591-018-0014-x

    Article  Google Scholar 

  2. Blackford, A.L., Canto, M.I., Klein, A.P., Hruban, R.H., Goggins, M.: Recent trends in the incidence and survival of stage 1a pancreatic cancer: a surveillance, epidemiology, and end results analysis. JNCI J. Nat. Cancer Inst. 112, 11629–1169 (2020)

    Article  Google Scholar 

  3. Breiman, L.: Random forests. Mach. Learn. 45(1), 5–32 (2001). https://doi.org/10.1023/A:1010933404324

    Article  MATH  Google Scholar 

  4. Buitinck, L., et al.: API design for machine learning software: experiences from the scikit-learn project. arXiv preprint arXiv:1309.0238 (2013)

  5. Cabrita, R., et al.: Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature 577, 561–565 (2020). https://doi.org/10.1038/s41586-019-1914-8

    Article  Google Scholar 

  6. Carstens, J.L., et al.: Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Nat. Commun. 8, 15095 (2017)

    Article  Google Scholar 

  7. Castino, G.F., et al.: Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma. Oncoimmunology 5(4), e1085147 (2016). https://doi.org/10.1080/2162402X.2015.1085147

    Article  Google Scholar 

  8. Denardo, D.G., et al.: CD4+ T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16(2), 91–102 (2009). https://doi.org/10.1016/j.ccr.2009.06.018

    Article  Google Scholar 

  9. Dixon, P.M.: Ripley’s K Function. Statistics Reference Online, Wiley StatsRef (2014)

    Google Scholar 

  10. Ene-Obong, A., et al.: Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology 145(5), 1121–1132 (2013)

    Article  Google Scholar 

  11. Fridman, W.H., Zitvogel, L., Sautes-Fridman, C., Kroemer, G.: The immune contexture in cancer prognosis and treatment. Nat. Rev. Clin. Oncol. 14(12), 717–734 (2017). https://doi.org/10.1038/nrclinonc.2017.101

    Article  Google Scholar 

  12. Geurts, P., Ernst, D., Wehenkel, L.: Extremely randomized trees. Mach. Learn. 63(1), 3–42 (2006). https://doi.org/10.1007/s10994-006-6226-1

    Article  MATH  Google Scholar 

  13. Goltsev, Y., et al.: Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell 174(4), 968–981 (2018)

    Article  Google Scholar 

  14. Guyon, I., Weston, J., Barnhill, S., Vapnik, V.: Gene selection for cancer classification using support vector machines. Mach. Learn. 46(1), 389–422 (2002). https://doi.org/10.1023/A:1012487302797

    Article  MATH  Google Scholar 

  15. Hiraoka, N., Ino, Y., Yamazaki-Itoh, R., Kanai, Y., Kosuge, T., Shimada, K.: Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer. Br. J. Cancer 112(11), 1782 (2015)

    Article  Google Scholar 

  16. Jackson, H.W., Fischer, J.R., Zanotelli, V.R.T., Ali, H.R., Weber, W.P., Bodenmiller, B.: The single-cell pathology landscape of breast cancer. Nature 578, 615–620 (2019). https://doi.org/10.1038/s41586-019-1876-x

    Article  Google Scholar 

  17. Kleeff, J., et al.: Pancreatic cancer. Nat. Rev. Dis. Primers 2, 1–23 (2016). https://doi.org/10.1038/nrdp.2016.22

    Article  Google Scholar 

  18. Lutz, E.R., et al.: Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation. Cancer Immunol. Res. 2(7), 616–631 (2014)

    Article  Google Scholar 

  19. Masugi, Y., et al.: Characterization of spatial distribution of tumor-infiltrating CD8+ T cells refines their prognostic utility for pancreatic cancer survival. Mod. Pathol. (2019). https://doi.org/10.1038/s41379-019-0291-z

    Article  Google Scholar 

  20. Neesse, A., et al.: Stromal biology and therapy in pancreatic cancer: ready for clinical translation? Gut 68(1), 159–171 (2019)

    Article  Google Scholar 

  21. Nogueira, F.: Bayesian optimization: open source constrained global optimization tool for Python (2014)

    Google Scholar 

  22. Schietinger, A., Greenberg, P.D.: Tolerance and exhaustion: defining mechanisms of T cell dysfunction. Trends Immunol. 35(2), 51–60 (2014)

    Article  Google Scholar 

  23. Shiao, S.L., Ruffell, B., DeNardo, D.G., Faddegon, B.A., Park, C.C., Coussens, L.M.: TH2-polarized CD4+ T cells and macrophages limit efficacy of radiotherapy. Cancer Immunol. Res. 3(5), 518–525 (2015)

    Article  Google Scholar 

  24. Tsujikawa, T., et al.: Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis. Cell Rep. 19(1), 203–217 (2017). https://doi.org/10.1016/j.celrep.2017.03.037

    Article  Google Scholar 

  25. Zou, H., Hastie, T.: Regularization and variable selection via the elastic net. J. Roy. Stat. Soci.: Ser. B (Stat. Methodol.) 67(2), 301–320 (2005)

    Article  MathSciNet  Google Scholar 

Download references

Funding

YHC acknowledges funding from the NIH (U54CA209988, 1U01 CA224012). The study and analyses were funded by an AACR Stand Up to Cancer grant funded by the Lustgarten Foundation, and the Brenden-Colson Center for Pancreatic Care at OHSU. LMC acknowledges funding from the National Institutes of Health (1U01 CA224012, U2C CA233280, R01 CA223150, R01 CA226909, R21 HD099367), the Knight Cancer Institute, and the Brenden-Colson Center for Pancreatic Care at OHSU. RCS acknowledges funding from the NIH (1U01 CA224012, U2C CA233280, U54 CA209988, R01 CA196228, and R01 CA186241) and the Brenden-Colson Center for Pancreatic Care at OHSU. This study was also made possible with support from the Oregon Clinical & Translational Research Institute (OCTRI), which is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Award Number UL1TR002369. Human PDAC surgical resection specimens were obtained in accordance with the Declaration of Helsinki and acquired with IRB approval from Dana-Farber/Harvard Cancer Center, and the Oregon Pancreas Tissue Registry under OHSU IRB protocol # 3609. Additional PDAC archival surgical resection specimens were collected from consented patients enrolled in the multi-center phase 1b PRINCE clinical trial (NCT03214250, sponsored by Parker Institute for Cancer Immunotherapy).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young Hwan Chang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Gray, E. et al. (2020). Activation vs. Organization: Prognostic Implications of T and B Cell Features of the PDAC Microenvironment. In: Bebis, G., Alekseyev, M., Cho, H., Gevertz, J., Rodriguez Martinez, M. (eds) Mathematical and Computational Oncology. ISMCO 2020. Lecture Notes in Computer Science(), vol 12508. Springer, Cham. https://doi.org/10.1007/978-3-030-64511-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-64511-3_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-64510-6

  • Online ISBN: 978-3-030-64511-3

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics